Welcome to Medications.com

FDA OK brightens biotech’s options - Business Gazette

First, GlaxoSmithKline, the British pharmaceutical giant, ended a licensing agreement to apply the Advancis technology to Glaxo’s antibiotic Augmentin. ...

http://www.gazette.net/stories/02... | Posted: Thu Feb 14 16:47:07 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea